Literature DB >> 8051939

Production and disposal of medium-chain fatty acids in children with medium-chain acyl-CoA dehydrogenase deficiency.

S J Heales1, G N Thompson, A F Massoud, S Rahman, D Halliday, J V Leonard.   

Abstract

The effect of fasting on plasma concentrations of fatty acids has been determined in four children with medium-chain acyl-CoA dehydrogenase (MCAD) deficiency. In addition, the in vivo rate of octanoate oxidation was measured, using [1-13C]octanoate. In the three older children (1.5-11.2 years), fasting for up to 18 h stimulated lipolysis, as reflected by the increasing concentration of free fatty acids, but with little rise in concentrations of medium-chain fatty acids, octanoate, decanoate and cis-4-decenoate. In an infant (0.5 year), lipolysis was greater and was accompanied by rising concentrations of medium-chain fatty acids. After 13.5 h there was a rapid increase in the concentration of decanoate and cis-4-decenoate. The calculated in vivo rate of octanoate oxidation was substantial in all patients studied (6.4-13.1 mumol/kg per h) despite very low MCAD activity in vitro. It is concluded that under basal conditions the in vivo oxidation rate of medium-chain fatty acids is near normal in the four children studied with MCAD deficiency.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8051939     DOI: 10.1007/bf00735398

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  7 in total

1.  Medium chain acyl CoA dehydrogenase deficiency.

Authors: 
Journal:  Lancet       Date:  1991-08-31       Impact factor: 79.321

2.  The fasting test in paediatrics: application to the diagnosis of pathological hypo- and hyperketotic states.

Authors:  J P Bonnefont; N B Specola; A Vassault; A Lombes; H Ogier; J B de Klerk; A Munnich; M Coude; M Paturneau-Jouas; J M Saudubray
Journal:  Eur J Pediatr       Date:  1990-12       Impact factor: 3.183

3.  How valid are isotopic measurements of fatty acid oxidation?

Authors:  V J Heiling; J M Miles; M D Jensen
Journal:  Am J Physiol       Date:  1991-11

4.  Effect of treatment with glycine and L-carnitine in medium-chain acyl-coenzyme A dehydrogenase deficiency.

Authors:  P Rinaldo; E Schmidt-Sommerfeld; A P Posca; S J Heales; D A Woolf; J V Leonard
Journal:  J Pediatr       Date:  1993-04       Impact factor: 4.406

5.  Tracer priming the bicarbonate pool.

Authors:  J R Allsop; R R Wolfe; J F Burke
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1978-07

6.  Rapid diagnosis of medium-chain acyl CoA dehydrogenase deficiency by measurement of cis-4-decenoic acid in plasma.

Authors:  S J Heales; D A Woolf; P Robinson; J V Leonard
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

7.  Purification and characterization of short-chain, medium-chain, and long-chain acyl-CoA dehydrogenases from rat liver mitochondria. Isolation of the holo- and apoenzymes and conversion of the apoenzyme to the holoenzyme.

Authors:  Y Ikeda; K Okamura-Ikeda; K Tanaka
Journal:  J Biol Chem       Date:  1985-01-25       Impact factor: 5.157

  7 in total
  9 in total

1.  Normal rates of whole-body fat oxidation and gluconeogenesis after overnight fasting and moderate-intensity exercise in patients with medium-chain acyl-CoA dehydrogenase deficiency.

Authors:  Hidde H Huidekoper; Mariëtte T Ackermans; René Koopman; Luc J C van Loon; Hans P Sauerwein; Frits A Wijburg
Journal:  J Inherit Metab Dis       Date:  2012-09-14       Impact factor: 4.982

2.  Ketonuria and medium-chain acyl-CoA dehydrogenase deficiency.

Authors:  J S Patel; J V Leonard
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

Review 3.  Tolerance to fast: rational and practical evaluation in children with hypoketonaemia.

Authors:  J H Walter
Journal:  J Inherit Metab Dis       Date:  2009-03-04       Impact factor: 4.982

4.  Risk stratification by residual enzyme activity after newborn screening for medium-chain acyl-CoA dehyrogenase deficiency: data from a cohort study.

Authors:  Catharina M L Touw; G Peter A Smit; Maaike de Vries; Johannis B C de Klerk; Annet M Bosch; Gepke Visser; Margot F Mulder; M Estela Rubio-Gozalbo; Bert Elvers; Klary E Niezen-Koning; Ronald J A Wanders; Hans R Waterham; Dirk-Jan Reijngoud; Terry G J Derks
Journal:  Orphanet J Rare Dis       Date:  2012-05-25       Impact factor: 4.123

5.  Living on the edge: substrate competition explains loss of robustness in mitochondrial fatty-acid oxidation disorders.

Authors:  Karen van Eunen; Catharina M L Volker-Touw; Albert Gerding; Aycha Bleeker; Justina C Wolters; Willemijn J van Rijt; Anne-Claire M F Martines; Klary E Niezen-Koning; Rebecca M Heiner; Hjalmar Permentier; Albert K Groen; Dirk-Jan Reijngoud; Terry G J Derks; Barbara M Bakker
Journal:  BMC Biol       Date:  2016-12-07       Impact factor: 7.431

6.  The promiscuous enzyme medium-chain 3-keto-acyl-CoA thiolase triggers a vicious cycle in fatty-acid beta-oxidation.

Authors:  Anne-Claire M F Martines; Karen van Eunen; Dirk-Jan Reijngoud; Barbara M Bakker
Journal:  PLoS Comput Biol       Date:  2017-04-03       Impact factor: 4.475

Review 7.  Flux analysis of inborn errors of metabolism.

Authors:  D-J Reijngoud
Journal:  J Inherit Metab Dis       Date:  2018-01-09       Impact factor: 4.982

8.  Transcriptome analysis suggests a compensatory role of the cofactors coenzyme A and NAD+ in medium-chain acyl-CoA dehydrogenase knockout mice.

Authors:  Anne-Claire M F Martines; Albert Gerding; Sarah Stolle; Marcel A Vieira-Lara; Justina C Wolters; Angelika Jurdzinski; Laura Bongiovanni; Alain de Bruin; Pieter van der Vlies; Gerben van der Vries; Vincent W Bloks; Terry G J Derks; Dirk-Jan Reijngoud; Barbara M Bakker
Journal:  Sci Rep       Date:  2019-10-10       Impact factor: 4.379

9.  In vitro and in vivo consequences of variant medium-chain acyl-CoA dehydrogenase genotypes.

Authors:  Catharina M L Touw; G Peter A Smit; Klary E Niezen-Koning; Conny Bosgraaf-de Boer; Albert Gerding; Dirk-Jan Reijngoud; Terry G J Derks
Journal:  Orphanet J Rare Dis       Date:  2013-03-20       Impact factor: 4.123

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.